Product Information

ROSUVASTATIN CALCIUM 20 MG TAB is a generic product labeled by American Health Packaging, priced at $0.0449 per EA under NDC 60687025601. Its NADAC has been published 515 times since Oct 12, 2016.

FDA first approved this application on Jul 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Rosuvastatin Calcium market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ROSUVASTATIN CALCIUM 20 MG TAB

Rosuvastatin Calcium
$0.0449per EA
Low Outlier

Strength

20 mg/1

NDC

60687025601

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ROSUVASTATIN CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA079170

FDA Approved

7/19/2016

TE Code

AB

On Market Since

9/21/2016

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ROSUVASTATIN CALCIUM 20 MG TAB has been published 515 times since Oct 12, 2016, and over the history we have for it it has declined 88.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0449 per EA
All-time high$0.4028 (Oct 12, 2016)
All-time low$0.0449 (Aug 19, 2026)
52-week high$0.0573
52-week low$0.0449
Median price$0.0788
Average price$0.0983
Largest weekly change+25.1% (Aug 21, 2024)
Weeks tracked515
Tracking sinceOct 12, 2016

Price History

1W

-1.4%

1M

-1.4%

3M

-5.8%

6M

-10.6%

1Y

-21.6%

3Y

-38.4%

5Y

-44.3%

All

-88.9%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ROSUVASTATIN CALCIUM 20 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 20 MG TAB, manufactured by American Health Packaging, is $0.0449 per EA (NDC 60687025601), effective Aug 19, 2026.

How has the price of ROSUVASTATIN CALCIUM 20 MG TAB changed over time?

Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 20 MG TAB has declined 88.9%. It has been tracked across 515 weekly CMS publications since Oct 12, 2016.

What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 20 MG TAB?

Since Oct 12, 2016, the NADAC for ROSUVASTATIN CALCIUM 20 MG TAB has ranged from a low of $0.0449 (Aug 19, 2026) to a high of $0.4028 (Oct 12, 2016), with a median of $0.0788 per EA.

Are there cheaper alternatives to ROSUVASTATIN CALCIUM 20 MG TAB?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROSUVASTATIN CALCIUM 20 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures ROSUVASTATIN CALCIUM 20 MG TAB?

ROSUVASTATIN CALCIUM 20 MG TAB (NDC 60687025601) is labeled by American Health Packaging, and CMS classifies it as a generic product.